News

Unveiling Medicare Advantage's Struggles with Patient Access

Unveiling Medicare Advantage's Struggles with Patient Access

Medicare Advantage and the Challenges It Presents

Recent findings from Walnut Hill Medical reveal alarming barriers within Medicare Advantage plans that are causing delays, denials, and even patient abandonment. The proprietary research sheds light on significant systemic issues affecting patients seeking advanced chronic pain treatment through Medicare Advantage, highlighting the broader concerns of transparency and equity within America's healthcare system.

Understanding Medicare Advantage

Medicare Advantage, also known as Medicare Part C, serves as a private alternative to traditional Medicare. With over half of all Medicare beneficiaries enrolled, these plans are managed by private insurance companies. While they often promote additional benefits, they enforce stricter regulations, including requirements for prior authorization (PA), which can hinder timely access to essential medical services.

The Role of Prior Authorization

Prior authorization demands that healthcare providers obtain approval from insurers before a patient receives specific treatments. Although this process aims to verify medical necessity and manage costs, it frequently leads to unnecessary delays in patient care and can result in outright denial of services.

The Implications of Denial on Patient Care

Data from Walnut Hill's recent study gathered from 1,210 patients illustrates that the problem is severe. A notable 29% of patients faced denial on their initial attempts to receive authorization for the minimally invasive therapy known as Peripheral Nerve Stimulation (PNS). This finding is over double the denial rate reported by the Office of Inspector General in a previous year.

Consequences of Denials

Following their initial denial, 28% of patients chose to abandon their pursuit of care altogether, refraining from appeals or resubmissions. Among those who did challenge the decision, 56% succeeded in overturning their denials. Remarkably, 69% of those who escalated their cases to a Medicare hearing successfully gained approval.

Chris Hanna, CEO of Walnut Hill Medical, emphasized the unnecessary burdens that prior authorization places on patients, asserting that the system acts as a gatekeeper that disproportionately impacts those without the means or advocacy to navigate the appeals process.

Financial Ramifications of Denials

The study reveals that of the patients analyzed, 210 were denied access to their PNS therapy, resulting in a staggering $6.2 million worth of care being withheld. This statistic starkly illustrates how administrative complexities can detract from patient well-being, as necessary treatments are not rendered due to procedural obstacles.

Call for Urgent Reform

Given that Medicare Advantage is now a principal provider for many eligible seniors, there arises a pressing need for reform within this system. Hanna argues that accountability must be prioritized to ensure that prior authorization is not leveraged as a barrier to care.

Walnut Hill is advocating for lawmakers to enhance transparency and accountability measures as part of the legislative push to amend the Improving Seniors' Timely Access to Care Act of 2025, introduced by a bipartisan group in Congress.

Conclusion and Future Directions

In summary, the findings from Walnut Hill Medical’s MAD Study highlight the critical issues surrounding Medicare Advantage plans and their implications for patient care. As these plans continue to dominate the coverage landscape for seniors, ongoing evaluation and reform become essential to rectify the barriers that too often impede access to needed treatments.

Frequently Asked Questions

What are the main findings of the Walnut Hill MAD Study?

The study reveals systemic delays and denials in accessing crucial chronic pain treatments for Medicare Advantage patients, significantly impacting their healthcare experience.

How does prior authorization affect patient care?

Prior authorization can delay necessary treatments and lead to denials, burdensome processes that may overwhelm patients and deter them from pursuing care.

What is Peripheral Nerve Stimulation (PNS)?

PNS is a minimally invasive and FDA-approved therapy designed to treat chronic pain effectively.

What percentage of patients were denied care in the study?

29% of patients encountered a denial during their first prior authorization attempt, underscoring the challenges they face.

What reforms are being proposed for Medicare Advantage?

Walnut Hill is urging lawmakers to enhance transparency and accountability within Medicare Advantage, emphasizing the necessity for legislative reform to improve patient access to care.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Duetti, CesiumAstro, and a Busy NYSE Capital Morning

Updated Category News Views 78

Three very different piles of money are jamming up the November 20 NYSE slate, and that contrast is the whole point. Private music catalogs, space-and-defense communications, and a new stock-and-bond ETF do not belong in the same bucket. Yet all three are competing for investor attention before the opening bell, alongside Danaos Corporation's 20th listing anniversary....

Continue Reading
Simmons Clarifies Texas Loan Exposure, But Risks Remain

Updated Category News Views 50

A $45 million discrepancy is not a rounding error, and Simmons First National has every reason to swat it down hard. The bank says recent reporting overstated financing tied to a Texas multifamily development at $133 million. Its stated total is roughly $88 million, with about $44 million participated to another financial institution. For shareholders in NASDAQ:SFNC, that...

Continue Reading
Story Cannabis Bets on Neighborly Thanksgiving Outreach

Updated Category News Views 58

A frozen turkey is not a grand strategy deck, thank goodness; it is dinner for a household that might be feeling the squeeze. Story Cannabis plans to hand out 840 of them on Tuesday, Nov. 24, splitting the giveaway between Columbus and Cleveland with former Ohio State and Dallas Cowboys running back Michael Wiley joining employees and volunteers. In a cannabis business...

Continue Reading
North Richland Hills Bets on Its Visitor Momentum Now

Updated Category News Views 65

A crowded family attraction map is a nice problem for a Texas city to have, and North Richland Hills is trying to turn that pile of assets into a cleaner regional tourism machine. On Nov. 20, 2026, the city introduced “The Place You Never Outgrow,” its first destination-marketing campaign, built with Flat Five Marketing. This is not a stock story in the usual...

Continue Reading
Kinross Lawsuit Puts Round Mountain Claims Under Fire

Updated Category News Views 0

A mine can swallow a rosy forecast faster than any spreadsheet admits. That is the ugly center of the proposed securities class action involving Kinross Gold: not merely that production guidance came down, but the allegation that investors were sold too much confidence before the operational reality at Round Mountain Phase S surfaced. NYSE:KGC dropped from $27.62 on...

Continue Reading
Webster First Takes Aim at the Youth Money Literacy Gap

Updated Category News Views 39

Money mistakes get expensive long before anyone calls them mistakes. That is the uncomfortable point beneath Webster First Federal Credit Union CEO John Thomasian's November 20, 2026 discussion of financial literacy: plenty of young adults are entering the real financial world with a card, a loan offer, and a phone full of banking apps, but no sturdy framework for using...

Continue Reading
TOP-REAL Tests Digital Monitoring in HER2 Cancer Care

Updated Category News Views 116

A cancer treatment can be extraordinarily potent and still get derailed by what happens on an ordinary Tuesday at home. That unglamorous gap between clinic visits is the whole point of TOP-REAL, a phase II academic study presented at ESMO AI & Digital Oncology 2026. Solti and its European partners are testing whether closer digital follow-up can catch trouble early enough...

Continue Reading
Flair's New Aviation Alliance Offers Options, Not Orders

Updated Category News Views 55

Aircraft shortages have a funny way of turning vague partnerships into very useful insurance policies. Flair Airlines, Phoenix Aviation Capital and Avia Solutions Group announced a Strategic Commercial Cooperation Agreement on Nov. 19, 2026, and the sensible reading is straightforward: the Canadian value carrier wants more ways to solve capacity and operational problems...

Continue Reading
Charter Investigation Puts ACP Exit Claims Under Lens

Updated Category News Views 13

Charter’s ACP hangover has grown from an operating headache into a governance question. Kahn Swick & Foti said on November 20, 2026, that it has begun investigating whether Charter Communications officers or directors breached fiduciary duties or otherwise broke state or federal law. That is not a finding of wrongdoing, and investors ought to keep that distinction...

Continue Reading
Arizona's Dry Climate Puts Scalp Health Under Stress

Updated Category News Views 65

Desert weather is unforgiving, and apparently the scalp does not get a pass. In a Nov. 20, 2026 discussion, Scottsdale and Tucson hair-restoration physician Dr. Sharon A. Keene frames Arizona hair concerns around something easy to overlook: the condition of the skin beneath the hair. That is a more sensible starting point than treating every strand in the shower like it...

Continue Reading

Top 5 Most Recently Viewed Articles

BlackBerry QNX and Pi Square Join Forces to Advance Indian Tech

Updated Category News Views 333

BlackBerry QNX Partners with Pi Square Technologies BlackBerry Limited (NYSE: BB) is experiencing a notable increase in share prices, reflecting growing investor confidence. Expanding Horizons for Engineers Recently, BlackBerry’s QNX division announced an exciting multi-year collaboration with Pi Square Technologies. This initiative aims to train thousands of engineers...

Continue Reading
Investors Urged to Act: Investigating DexCom Securities Claims

Updated Category News Views 67

Understanding the Ongoing Investigations into DexCom Faruqi & Faruqi, LLP, a prominent national securities law firm, is currently investigating potential claims on behalf of investors affected by losses in DexCom, Inc. (NASDAQ: DXCM). This inquiry is a direct response to significant concerns raised about the company's business practices and market performance. The Scope...

Continue Reading
Legal Battle Heats Up for Michigan Auto Attorney Over CURE

Updated Category News Views 299

Michigan Attorney Faces Legal Challenges Amid CURE Controversy In a recent turn of events, an attorney from Michigan is experiencing the challenges of navigating legal waters after speaking out against CURE Auto Insurance. The attorney, Steven M. Gursten, along with his firm Michigan Auto Law, is embroiled in lawsuits that highlight serious concerns about consumer...

Continue Reading
Investors of Joint Stock Company Kaspi.kz (KSPI) Take Action Now

Updated Category News Views 120

Investors of Joint Stock Company Kaspi.kz (NASDAQ: KSPI) Take Action Attention investors of Joint Stock Company Kaspi.kz, also known as KSPI! A recent report has raised serious concerns regarding the company's activities, prompting investors who have experienced losses to consider their options in filing a securities fraud lawsuit. These troubling developments are crucial...

Continue Reading
Investors Guide: Urgent Action Needed for Western Asset Fund

Updated Category News Views 130

Introduction to the Class Action The Rosen Law Firm, a prominent name in investor rights advocacy, is urging investors in the Western Asset Management Company mutual funds to take action before an important deadline. If you invested in the 'Western Asset US Core Bond Fund' or the 'Western Asset Core Plus Bond Fund' during the designated class period, this message is...

Continue Reading